(Q52081442)

21 April 2018

title

A retrospective analysis of pharmacokinetic/pharmacodynamic indices as indicators of the clinical efficacy of ciprofloxacin. (English)

1 reference

21 April 2018

1 reference

1 reference

Sánchez-Recio MM

1

1 reference

21 April 2018

Colino CI

series ordinal

2

1 reference

21 April 2018

Sánchez-Navarro A

series ordinal

3

1 reference

21 April 2018

language of work or name

English

0 references

publication date

1 March 2000

1 reference

21 April 2018

Journal of Antimicrobial Chemotherapy

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 April 2018

volume

45

1 reference

21 April 2018

issue

3

1 reference

21 April 2018

page(s)

321-328

1 reference

21 April 2018

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Pharmacokinetics and pharmacodynamics of newer fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Role of pharmacokinetics in the outcome of infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

AUIC--a general target for the optimization of dosing regimens of antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Comparison of ciprofloxacin with ampicillin in acute infectious exacerbations of chronic bronchitis. A double-blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

A randomised, multinational study with sequential therapy comparing ciprofloxacin twice daily and ofloxacin once daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Safety and efficacy of intravenous ciprofloxacin in the treatment of selected infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

The Alexander Project: using in-vitro susceptibility data for choosing empirical therapy in LRTI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Absolute oral bioavailability of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

Statistical moments in pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F45.3.321

21 January 2018

Identifiers

DOI

10.1093/JAC/45.3.321

1 reference

21 April 2018

1 reference

21 April 2018